[IMCAS World Congress 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ⑮ | Interview with Chanjong Lee, Medical Director of DEXLEVO
As the global anti-aging market shifts toward 'Back to the Time' — the desire to restore skin to its state three to five years ago — DEXLEVO is emerging as a driving force behind this movement. GOURI, a liquid PCL collagen stimulator built on the company's proprietary CESABP technology, has been exported to 50 countries with cumulative usage approaching one million syringes since obtaining European CE certification in 2021. With MFDS approval secured in October 2025, DEXLEVO has completed a distinctive market entry strategy: global validation first, then domestic launch. At IMCAS World Congress 2026 in Paris, Medical Director Chanjong Lee outlined plans for an expanded ampoule lineup and IPO preparations, underscoring the company's commitment to positioning DEXLEVO as the central force driving K-Medical Aesthetics to global leadership. Read the full interview via the link in our bio.
#MedicalAestheticNews #IMCAS2026 #DEXLEVO #GOURI #CollagenStimulator #KMedicalAesthetics
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11241

Comments
Post a Comment